Evidence map›Paper›PMID 28830516›Full record

ArticleAlzheimer's research & therapy2017

Cost of diagnosing dementia in a German memory clinic.

Bernhard Michalowsky, Steffen Flessa, Johannes Hertel, Olav Goetz, Wolfgang Hoffmann, Stefan Teipel, Ingo Kilimann

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bernhard MichalowskyDeutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE) Standort Rostock/Greifswald, Greifswald, Germany. bernhard.michalowsky@dzne.de.ORCID http://orcid.org/0000-0002-3425-0089
Steffen FlessaDepartment of General Business Administration and Health Care Management, Ernst Moritz Arndt University Greifswald, Greifswald, D-17489, Germany.
Johannes HertelDeutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE) Standort Rostock/Greifswald, Greifswald, Germany.
Olav GoetzDepartment of General Business Administration and Health Care Management, Ernst Moritz Arndt University Greifswald, Greifswald, D-17489, Germany.
Wolfgang HoffmannDeutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE) Standort Rostock/Greifswald, Greifswald, Germany.
Stefan TeipelDepartment of Psychosomatic Medicine, University Hospital Rostock, and German Centre for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Rostock, Gehlsheimer Strasse 20, D-18147, Germany.
Ingo KilimannDepartment of Psychosomatic Medicine, University Hospital Rostock, and German Centre for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Rostock, Gehlsheimer Strasse 20, D-18147, Germany.
Universität Greifswald · DEUniversitätsmedizin Greifswald · DEGerman Center for Neurodegenerative Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known about diagnostic work-ups or the costs of diagnosing dementia in specialized care. Here, we analyzed the costs of diagnosing dementia according to specific dementia disorders.

methodsA prospective descriptive design was used to analyze the cost of diagnosing dementia for 120 patients with suspected dementia at a German memory clinic. The duration of clinical consultations and use of technical procedures were recorded by the memory clinic staff. To detect cost drivers, a multiple linear regression model was used.

resultsOf patients with suspected dementia, 44% were diagnosed with dementia. The total cost per patient and diagnostic process amounted to 501 € across all patients and 659 € for patients who were diagnosed with dementia. The costs varied between 649 € for patients with Alzheimer's disease, 662 € for patients with vascular or mixed dementia, and 705 € for patients with unspecific dementia. A final diagnosis of dementia was the only factor that was significantly associated with the diagnostic cost (b = 356, CI

conclusionThe high range of costs reflects differences in diagnostic demands depending on the etiology of dementia. This variation needs to be transferred into reimbursement. Further studies are needed to assess the influence of the type of cognitive impairment and of the setting on diagnostic costs.

Indexed as

Health Care CostsAgedAged, 80 and overCognitive DysfunctionDementiaFemaleGermanyHumansLinear ModelsMaleMiddle AgedProspective StudiesAlzheimer’s diseaseDementiaDiagnosesHealthcare costHealthcare economics and organizations

Identifiers

PMID28830516
PMCPMC5568303
OpenAlexW2748821357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.